APA (7th ed.) Citation

Y, X., P, Z., Z, Y., T, S., S, D., Y, H., . . . H, X. (2026). CRYM suppresses glioblastoma progression by inhibiting the TGFβ1/Smad-EMT signaling pathway. Journal of neuro-oncology, 177(2), . https://doi.org/10.1007/s11060-026-05486-7

Chicago Style (17th ed.) Citation

Y, Xu, et al. "CRYM Suppresses Glioblastoma Progression by Inhibiting the TGFβ1/Smad-EMT Signaling Pathway." Journal of Neuro-oncology 177, no. 2 (2026). https://doi.org/10.1007/s11060-026-05486-7.

MLA (9th ed.) Citation

Y, Xu, et al. "CRYM Suppresses Glioblastoma Progression by Inhibiting the TGFβ1/Smad-EMT Signaling Pathway." Journal of Neuro-oncology, vol. 177, no. 2, 2026, https://doi.org/10.1007/s11060-026-05486-7.